208 related articles for article (PubMed ID: 2464903)
1. Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients.
Nordin C
Acta Psychiatr Scand; 1988 Dec; 78(6):720-9. PubMed ID: 2464903
[TBL] [Abstract][Full Text] [Related]
2. Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers.
Alfredsson G; Wiesel FA; Tylec A
Biol Psychiatry; 1988 Apr; 23(7):689-97. PubMed ID: 2453224
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
Mårtensson B; Nyberg S; Toresson G; Brodin E; Bertilsson L
Acta Psychiatr Scand; 1989 Jun; 79(6):586-96. PubMed ID: 2475012
[TBL] [Abstract][Full Text] [Related]
4. CSF amine metabolites and depression.
Peabody CA; Faull KF; King RJ; Whiteford HA; Barchas JD; Berger PA
Psychiatry Res; 1987 May; 21(1):1-7. PubMed ID: 2440071
[TBL] [Abstract][Full Text] [Related]
5. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
Andersen O; Johansson BB; Svennerholm L
Acta Neurol Scand; 1981 Apr; 63(4):247-54. PubMed ID: 6163303
[TBL] [Abstract][Full Text] [Related]
6. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G
Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
[TBL] [Abstract][Full Text] [Related]
7. CSF monoamine metabolites of depressed patients during illness and after recovery.
Träskman-Bendz L; Asberg M; Bertilsson L; Thorén P
Acta Psychiatr Scand; 1984 Apr; 69(4):333-42. PubMed ID: 6202099
[TBL] [Abstract][Full Text] [Related]
8. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
Sjöström R; Ekstedt J; Anggård E
J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
[TBL] [Abstract][Full Text] [Related]
9. CSF monoamine metabolites in schizophrenic patients.
Gattaz WF; Waldmeier P; Beckmann H
Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
[TBL] [Abstract][Full Text] [Related]
10. CSF monoamine metabolites in melancholia.
Asberg M; Bertilsson L; Mårtensson B; Scalia-Tomba GP; Thorén P; Träskman-Bendz L
Acta Psychiatr Scand; 1984 Mar; 69(3):201-19. PubMed ID: 6201041
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
[TBL] [Abstract][Full Text] [Related]
12. Monoamine metabolites in CSF and suicidal behavior.
Träskman L; Asberg M; Bertilsson L; Sjöstrand L
Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274
[TBL] [Abstract][Full Text] [Related]
13. Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.
Bråne G; Gottfries CG; Blennow K; Karlsson I; Lekman A; Parnetti L; Svennerholm L; Wallin A
Alzheimer Dis Assoc Disord; 1989; 3(3):148-56. PubMed ID: 2477044
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.
Redmond DE; Katz MM; Maas JW; Swann A; Casper R; Davis JM
Arch Gen Psychiatry; 1986 Oct; 43(10):938-47. PubMed ID: 2428328
[TBL] [Abstract][Full Text] [Related]
15. Consistent evidence for a biological subtype of depression characterized by low CSF monoamine levels.
Gibbons RD; Davis JM
Acta Psychiatr Scand; 1986 Jul; 74(1):8-12. PubMed ID: 2429500
[TBL] [Abstract][Full Text] [Related]
16. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
[TBL] [Abstract][Full Text] [Related]
17. Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.
Mendlewicz J; Pinder RM; Stulemeijer SM; Van Dorth R
J Affect Disord; 1982 Sep; 4(3):219-26. PubMed ID: 6182175
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
De Bellis MD; Geracioti TD; Altemus M; Kling MA
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age.
Blennow K; Wallin A; Gottfries CG; Karlsson I; Månsson JE; Skoog I; Wikkelsö C; Svennerholm L
Eur Neuropsychopharmacol; 1993 Mar; 3(1):55-61. PubMed ID: 7682460
[TBL] [Abstract][Full Text] [Related]
20. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: I. General patterns.
Agren H
Psychiatry Res; 1980 Oct; 3(2):211-23. PubMed ID: 6171840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
